🟢 Nutex Health is trading 7.4% up today after Q2 adjusted EPS beats estimates

Nutex Health is trading at $174.02, up +7.37%, after reporting Q2 adjusted EPS of $9.38, above the $4.88 estimate.

• The move extends Nutex Health’s August 7 rally; revenue reached $210.75 million despite declining revenue.
• Profitability was supported by lower arbitration costs, retroactive expense relief, and stronger cash generation.
• Broader markets are slightly weaker, suggesting the move is primarily company-specific rather than market-driven.